Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse, Serial No. 113-140, April 29, 2014, 113-2
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 192
Book Description
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 192
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse
Author: United States. Congress
Publisher: Createspace Independent Publishing Platform
ISBN: 9781981345410
Category :
Languages : en
Pages : 190
Book Description
Examining the growing problems of prescription drug and heroin abuse : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 29, 2014.
Publisher: Createspace Independent Publishing Platform
ISBN: 9781981345410
Category :
Languages : en
Pages : 190
Book Description
Examining the growing problems of prescription drug and heroin abuse : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 29, 2014.
Activity Report of the Committee on Energy and Commerce of the U.S. House of Representatives ... Together with Dissenting Views
Author: United States. Congress. House. Committee on Energy and Commerce
Publisher:
ISBN:
Category : Energy policy
Languages : en
Pages : 208
Book Description
Publisher:
ISBN:
Category : Energy policy
Languages : en
Pages : 208
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse
Author: United States Congress
Publisher: Createspace Independent Publishing Platform
ISBN: 9781981115662
Category :
Languages : en
Pages : 126
Book Description
Examining the growing problems of prescription drug and heroin abuse : state and local perspectives : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 26, 2015.
Publisher: Createspace Independent Publishing Platform
ISBN: 9781981115662
Category :
Languages : en
Pages : 126
Book Description
Examining the growing problems of prescription drug and heroin abuse : state and local perspectives : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 26, 2015.
Examining the Growing Problems of Prescription Drug and Heroin Abuse
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 0
Book Description
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 0
Book Description
Legislative Calendar
Author: United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs
Publisher:
ISBN:
Category :
Languages : en
Pages : 492
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 492
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse: State and Local Perspectives, Serial No. 114-27, March 26, 2015, 114-1
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Examining the Growing Problems of Prescription Drug and Heroin Abuse
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 122
Book Description
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 122
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.